| Today's Open | $6.13 |
|---|---|
| Previous Close | $6.11 |
| Daily Range | $5.99 - $6.38 |
| 52-Week Range | $3.10 - $7.73 |
| Market Cap | $585.8M |
| P/E Ratio | -4.63 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 1,249,563 |
| Average Daily Volume | 830,727 |
| Current FY EPS | -$0.78 |
Sector
Healthcare
Industry
Drugs
Orexigen Therapeutics, Inc. (OREX) Description
A biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system, disorders, with an initial focus on obesity. Website: http://www.orexigen.com/
News & Commentary
3 Pipeline Obesity Treatments You Should Watch
In the past year, two approved obesity drugs put the massive obesity market within reach of investors. Here are three treatments under development that could have even bigger consequences.The 9 Most Obese Countries in the World
Obesity trends are on the rise in these nine countries. See what's being done to counteract this potentially worrisome trend.Orexigen Therapeutics' Management Presents at Bank of America Merrill Lynch Health Care Conference -
Orexigen Therapeutics' Management Presents at Bank of America Merrill Lynch Health Care Conference - TranscriptWeight Loss Isn't Just for Looking Good Anymore
Medical benefits are helping obesity drugs get coverage. Will the government help?Is Orexigen Therapeutics Burning Too Much Cash?
What is this biotech's burn rate?OREX's Top Competitors
(1.31%)
(0.28%)
(-0.96%)
(0.75%)